ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global New Chemical Entities (NCE) Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-24J18569
Home | Market Reports | Business & Industrial| Chemicals Industry
Global New Chemical Entities NCE Market Research Report 2025
BUY CHAPTERS

Global New Chemical Entities (NCE) Market Research Report 2025

Code: QYRE-Auto-24J18569
Report
January 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
KATSURA CHEMICAL CO., LTD
Adragos Pharma
Syngene
Regis Custom API
Bachem
Suven Pharma
Aspen API
MedPharm Ltd.
Intertek
Neuland Laboratories
Piramal Pharma Solutions
Sai Life Sciences
Chempro Pharma
LG Chem
Sofpromed
Aurigene Pharmaceutical Services Ltd.
Aragen Life Sciences Ltd
WuXi AppTec
PharmaBlock Sciences (Nanjing), Inc.
NMS Group (Accelera Srl)

New Chemical Entities (NCE) Market Size

The global market for New Chemical Entities (NCE) was valued at US$ 4252 million in the year 2024 and is projected to reach a revised size of US$ 8590 million by 2031, growing at a CAGR of 11.2% during the forecast period.

New Chemical Entities (NCE) Market

New Chemical Entities (NCE) Market

During the drug discovery process, new compounds or active moieties (molecules or ions responsible for physiological or pharmacological action) can arise that have not previously been FDA-approved. These compounds are called New Chemical Entities (NCE) as they have not previously been used, and they can help bring about cures and therapies for incurable diseases such as cancer due to the novelty of the drug and or compound.In the existing market, there are already companies providing CDMO services for new chemical entities, and there are also companies providing new chemical entity discovery services, which can then be handed over to other companies for drug development.
North American market for New Chemical Entities (NCE) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for New Chemical Entities (NCE) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for New Chemical Entities (NCE) in Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of New Chemical Entities (NCE) include KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, Bachem, Suven Pharma, Aspen API, MedPharm, Intertek, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for New Chemical Entities (NCE), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Chemical Entities (NCE).
The New Chemical Entities (NCE) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global New Chemical Entities (NCE) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the New Chemical Entities (NCE) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of New Chemical Entities (NCE) Market Report

Report Metric Details
Report Name New Chemical Entities (NCE) Market
Accounted market size in year US$ 4252 million
Forecasted market size in 2031 US$ 8590 million
CAGR 11.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, Bachem, Suven Pharma, Aspen API, MedPharm, Intertek, Neuland Laboratories, Piramal Pharma Solutions, Sai Life Sciences, Chempro Pharma, LG Chem, Sofpromed, Aurigene Pharmaceutical Services Ltd., Aragen Life Sciences Ltd, WuXi AppTec, PharmaBlock Sciences Nanjing Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of New Chemical Entities (NCE) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is New Chemical Entities (NCE) Market growing?

Ans: The New Chemical Entities (NCE) Market witnessing a CAGR of 11.2% during the forecast period 2025-2031.

What is the New Chemical Entities (NCE) Market size in 2031?

Ans: The New Chemical Entities (NCE) Market size in 2031 will be US$ 8590 million.

Who are the main players in the New Chemical Entities (NCE) Market report?

Ans: The main players in the New Chemical Entities (NCE) Market are KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, Bachem, Suven Pharma, Aspen API, MedPharm, Intertek, Neuland Laboratories, Piramal Pharma Solutions, Sai Life Sciences, Chempro Pharma, LG Chem, Sofpromed, Aurigene Pharmaceutical Services Ltd., Aragen Life Sciences Ltd, WuXi AppTec, PharmaBlock Sciences Nanjing Inc

What are the Application segmentation covered in the New Chemical Entities (NCE) Market report?

Ans: The Applications covered in the New Chemical Entities (NCE) Market report are Tumors, Cardiovascular Diseases, Other

What are the Type segmentation covered in the New Chemical Entities (NCE) Market report?

Ans: The Types covered in the New Chemical Entities (NCE) Market report are NCE Discovery, Drug Formulation Development, Large-scale Manufacturing

Recommended Reports

Cancer Therapy Markets

Drug Discovery & CDMO

Diagnostics & Targeted Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Chemical Entities (NCE) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NCE Discovery
1.2.3 Drug Formulation Development
1.2.4 Large-scale Manufacturing
1.3 Market by Application
1.3.1 Global New Chemical Entities (NCE) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumors
1.3.3 Cardiovascular Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Chemical Entities (NCE) Market Perspective (2020-2031)
2.2 Global New Chemical Entities (NCE) Growth Trends by Region
2.2.1 Global New Chemical Entities (NCE) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 New Chemical Entities (NCE) Historic Market Size by Region (2020-2025)
2.2.3 New Chemical Entities (NCE) Forecasted Market Size by Region (2026-2031)
2.3 New Chemical Entities (NCE) Market Dynamics
2.3.1 New Chemical Entities (NCE) Industry Trends
2.3.2 New Chemical Entities (NCE) Market Drivers
2.3.3 New Chemical Entities (NCE) Market Challenges
2.3.4 New Chemical Entities (NCE) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Chemical Entities (NCE) Players by Revenue
3.1.1 Global Top New Chemical Entities (NCE) Players by Revenue (2020-2025)
3.1.2 Global New Chemical Entities (NCE) Revenue Market Share by Players (2020-2025)
3.2 Global New Chemical Entities (NCE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by New Chemical Entities (NCE) Revenue
3.4 Global New Chemical Entities (NCE) Market Concentration Ratio
3.4.1 Global New Chemical Entities (NCE) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Chemical Entities (NCE) Revenue in 2024
3.5 Global Key Players of New Chemical Entities (NCE) Head office and Area Served
3.6 Global Key Players of New Chemical Entities (NCE), Product and Application
3.7 Global Key Players of New Chemical Entities (NCE), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 New Chemical Entities (NCE) Breakdown Data by Type
4.1 Global New Chemical Entities (NCE) Historic Market Size by Type (2020-2025)
4.2 Global New Chemical Entities (NCE) Forecasted Market Size by Type (2026-2031)
5 New Chemical Entities (NCE) Breakdown Data by Application
5.1 Global New Chemical Entities (NCE) Historic Market Size by Application (2020-2025)
5.2 Global New Chemical Entities (NCE) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America New Chemical Entities (NCE) Market Size (2020-2031)
6.2 North America New Chemical Entities (NCE) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America New Chemical Entities (NCE) Market Size by Country (2020-2025)
6.4 North America New Chemical Entities (NCE) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Chemical Entities (NCE) Market Size (2020-2031)
7.2 Europe New Chemical Entities (NCE) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe New Chemical Entities (NCE) Market Size by Country (2020-2025)
7.4 Europe New Chemical Entities (NCE) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New Chemical Entities (NCE) Market Size (2020-2031)
8.2 Asia-Pacific New Chemical Entities (NCE) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific New Chemical Entities (NCE) Market Size by Region (2020-2025)
8.4 Asia-Pacific New Chemical Entities (NCE) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New Chemical Entities (NCE) Market Size (2020-2031)
9.2 Latin America New Chemical Entities (NCE) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America New Chemical Entities (NCE) Market Size by Country (2020-2025)
9.4 Latin America New Chemical Entities (NCE) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Chemical Entities (NCE) Market Size (2020-2031)
10.2 Middle East & Africa New Chemical Entities (NCE) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa New Chemical Entities (NCE) Market Size by Country (2020-2025)
10.4 Middle East & Africa New Chemical Entities (NCE) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KATSURA CHEMICAL CO., LTD
11.1.1 KATSURA CHEMICAL CO., LTD Company Details
11.1.2 KATSURA CHEMICAL CO., LTD Business Overview
11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Introduction
11.1.4 KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.1.5 KATSURA CHEMICAL CO., LTD Recent Development
11.2 NMS Group (Accelera Srl)
11.2.1 NMS Group (Accelera Srl) Company Details
11.2.2 NMS Group (Accelera Srl) Business Overview
11.2.3 NMS Group (Accelera Srl) New Chemical Entities (NCE) Introduction
11.2.4 NMS Group (Accelera Srl) Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.2.5 NMS Group (Accelera Srl) Recent Development
11.3 Adragos Pharma
11.3.1 Adragos Pharma Company Details
11.3.2 Adragos Pharma Business Overview
11.3.3 Adragos Pharma New Chemical Entities (NCE) Introduction
11.3.4 Adragos Pharma Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.3.5 Adragos Pharma Recent Development
11.4 Syngene
11.4.1 Syngene Company Details
11.4.2 Syngene Business Overview
11.4.3 Syngene New Chemical Entities (NCE) Introduction
11.4.4 Syngene Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.4.5 Syngene Recent Development
11.5 Regis Custom API
11.5.1 Regis Custom API Company Details
11.5.2 Regis Custom API Business Overview
11.5.3 Regis Custom API New Chemical Entities (NCE) Introduction
11.5.4 Regis Custom API Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.5.5 Regis Custom API Recent Development
11.6 Bachem
11.6.1 Bachem Company Details
11.6.2 Bachem Business Overview
11.6.3 Bachem New Chemical Entities (NCE) Introduction
11.6.4 Bachem Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.6.5 Bachem Recent Development
11.7 Suven Pharma
11.7.1 Suven Pharma Company Details
11.7.2 Suven Pharma Business Overview
11.7.3 Suven Pharma New Chemical Entities (NCE) Introduction
11.7.4 Suven Pharma Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.7.5 Suven Pharma Recent Development
11.8 Aspen API
11.8.1 Aspen API Company Details
11.8.2 Aspen API Business Overview
11.8.3 Aspen API New Chemical Entities (NCE) Introduction
11.8.4 Aspen API Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.8.5 Aspen API Recent Development
11.9 MedPharm
11.9.1 MedPharm Company Details
11.9.2 MedPharm Business Overview
11.9.3 MedPharm New Chemical Entities (NCE) Introduction
11.9.4 MedPharm Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.9.5 MedPharm Recent Development
11.10 Intertek
11.10.1 Intertek Company Details
11.10.2 Intertek Business Overview
11.10.3 Intertek New Chemical Entities (NCE) Introduction
11.10.4 Intertek Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.10.5 Intertek Recent Development
11.11 Neuland Laboratories
11.11.1 Neuland Laboratories Company Details
11.11.2 Neuland Laboratories Business Overview
11.11.3 Neuland Laboratories New Chemical Entities (NCE) Introduction
11.11.4 Neuland Laboratories Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.11.5 Neuland Laboratories Recent Development
11.12 Piramal Pharma Solutions
11.12.1 Piramal Pharma Solutions Company Details
11.12.2 Piramal Pharma Solutions Business Overview
11.12.3 Piramal Pharma Solutions New Chemical Entities (NCE) Introduction
11.12.4 Piramal Pharma Solutions Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.12.5 Piramal Pharma Solutions Recent Development
11.13 Sai Life Sciences
11.13.1 Sai Life Sciences Company Details
11.13.2 Sai Life Sciences Business Overview
11.13.3 Sai Life Sciences New Chemical Entities (NCE) Introduction
11.13.4 Sai Life Sciences Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.13.5 Sai Life Sciences Recent Development
11.14 Chempro Pharma
11.14.1 Chempro Pharma Company Details
11.14.2 Chempro Pharma Business Overview
11.14.3 Chempro Pharma New Chemical Entities (NCE) Introduction
11.14.4 Chempro Pharma Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.14.5 Chempro Pharma Recent Development
11.15 LG Chem
11.15.1 LG Chem Company Details
11.15.2 LG Chem Business Overview
11.15.3 LG Chem New Chemical Entities (NCE) Introduction
11.15.4 LG Chem Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.15.5 LG Chem Recent Development
11.16 Sofpromed
11.16.1 Sofpromed Company Details
11.16.2 Sofpromed Business Overview
11.16.3 Sofpromed New Chemical Entities (NCE) Introduction
11.16.4 Sofpromed Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.16.5 Sofpromed Recent Development
11.17 Aurigene Pharmaceutical Services Ltd.
11.17.1 Aurigene Pharmaceutical Services Ltd. Company Details
11.17.2 Aurigene Pharmaceutical Services Ltd. Business Overview
11.17.3 Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Introduction
11.17.4 Aurigene Pharmaceutical Services Ltd. Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.17.5 Aurigene Pharmaceutical Services Ltd. Recent Development
11.18 Aragen Life Sciences Ltd
11.18.1 Aragen Life Sciences Ltd Company Details
11.18.2 Aragen Life Sciences Ltd Business Overview
11.18.3 Aragen Life Sciences Ltd New Chemical Entities (NCE) Introduction
11.18.4 Aragen Life Sciences Ltd Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.18.5 Aragen Life Sciences Ltd Recent Development
11.19 WuXi AppTec
11.19.1 WuXi AppTec Company Details
11.19.2 WuXi AppTec Business Overview
11.19.3 WuXi AppTec New Chemical Entities (NCE) Introduction
11.19.4 WuXi AppTec Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.19.5 WuXi AppTec Recent Development
11.20 PharmaBlock Sciences Nanjing Inc
11.20.1 PharmaBlock Sciences Nanjing Inc Company Details
11.20.2 PharmaBlock Sciences Nanjing Inc Business Overview
11.20.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Introduction
11.20.4 PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) Business (2020-2025)
11.20.5 PharmaBlock Sciences Nanjing Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
KATSURA CHEMICAL CO., LTD
Adragos Pharma
Syngene
Regis Custom API
Bachem
Suven Pharma
Aspen API
MedPharm Ltd.
Intertek
Neuland Laboratories
Piramal Pharma Solutions
Sai Life Sciences
Chempro Pharma
LG Chem
Sofpromed
Aurigene Pharmaceutical Services Ltd.
Aragen Life Sciences Ltd
WuXi AppTec
PharmaBlock Sciences (Nanjing), Inc.
NMS Group (Accelera Srl)
List of Tables
 Table 1. Global New Chemical Entities (NCE) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of NCE Discovery
 Table 3. Key Players of Drug Formulation Development
 Table 4. Key Players of Large-scale Manufacturing
 Table 5. Global New Chemical Entities (NCE) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global New Chemical Entities (NCE) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global New Chemical Entities (NCE) Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global New Chemical Entities (NCE) Market Share by Region (2020-2025)
 Table 9. Global New Chemical Entities (NCE) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global New Chemical Entities (NCE) Market Share by Region (2026-2031)
 Table 11. New Chemical Entities (NCE) Market Trends
 Table 12. New Chemical Entities (NCE) Market Drivers
 Table 13. New Chemical Entities (NCE) Market Challenges
 Table 14. New Chemical Entities (NCE) Market Restraints
 Table 15. Global New Chemical Entities (NCE) Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global New Chemical Entities (NCE) Market Share by Players (2020-2025)
 Table 17. Global Top New Chemical Entities (NCE) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) as of 2024)
 Table 18. Ranking of Global Top New Chemical Entities (NCE) Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by New Chemical Entities (NCE) Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of New Chemical Entities (NCE), Headquarters and Area Served
 Table 21. Global Key Players of New Chemical Entities (NCE), Product and Application
 Table 22. Global Key Players of New Chemical Entities (NCE), Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global New Chemical Entities (NCE) Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global New Chemical Entities (NCE) Revenue Market Share by Type (2020-2025)
 Table 26. Global New Chemical Entities (NCE) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global New Chemical Entities (NCE) Revenue Market Share by Type (2026-2031)
 Table 28. Global New Chemical Entities (NCE) Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global New Chemical Entities (NCE) Revenue Market Share by Application (2020-2025)
 Table 30. Global New Chemical Entities (NCE) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global New Chemical Entities (NCE) Revenue Market Share by Application (2026-2031)
 Table 32. North America New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America New Chemical Entities (NCE) Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America New Chemical Entities (NCE) Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe New Chemical Entities (NCE) Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe New Chemical Entities (NCE) Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific New Chemical Entities (NCE) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific New Chemical Entities (NCE) Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific New Chemical Entities (NCE) Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America New Chemical Entities (NCE) Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America New Chemical Entities (NCE) Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa New Chemical Entities (NCE) Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa New Chemical Entities (NCE) Market Size by Country (2026-2031) & (US$ Million)
 Table 47. KATSURA CHEMICAL CO., LTD Company Details
 Table 48. KATSURA CHEMICAL CO., LTD Business Overview
 Table 49. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Product
 Table 50. KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 51. KATSURA CHEMICAL CO., LTD Recent Development
 Table 52. NMS Group (Accelera Srl) Company Details
 Table 53. NMS Group (Accelera Srl) Business Overview
 Table 54. NMS Group (Accelera Srl) New Chemical Entities (NCE) Product
 Table 55. NMS Group (Accelera Srl) Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 56. NMS Group (Accelera Srl) Recent Development
 Table 57. Adragos Pharma Company Details
 Table 58. Adragos Pharma Business Overview
 Table 59. Adragos Pharma New Chemical Entities (NCE) Product
 Table 60. Adragos Pharma Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 61. Adragos Pharma Recent Development
 Table 62. Syngene Company Details
 Table 63. Syngene Business Overview
 Table 64. Syngene New Chemical Entities (NCE) Product
 Table 65. Syngene Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 66. Syngene Recent Development
 Table 67. Regis Custom API Company Details
 Table 68. Regis Custom API Business Overview
 Table 69. Regis Custom API New Chemical Entities (NCE) Product
 Table 70. Regis Custom API Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 71. Regis Custom API Recent Development
 Table 72. Bachem Company Details
 Table 73. Bachem Business Overview
 Table 74. Bachem New Chemical Entities (NCE) Product
 Table 75. Bachem Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 76. Bachem Recent Development
 Table 77. Suven Pharma Company Details
 Table 78. Suven Pharma Business Overview
 Table 79. Suven Pharma New Chemical Entities (NCE) Product
 Table 80. Suven Pharma Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 81. Suven Pharma Recent Development
 Table 82. Aspen API Company Details
 Table 83. Aspen API Business Overview
 Table 84. Aspen API New Chemical Entities (NCE) Product
 Table 85. Aspen API Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 86. Aspen API Recent Development
 Table 87. MedPharm Company Details
 Table 88. MedPharm Business Overview
 Table 89. MedPharm New Chemical Entities (NCE) Product
 Table 90. MedPharm Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 91. MedPharm Recent Development
 Table 92. Intertek Company Details
 Table 93. Intertek Business Overview
 Table 94. Intertek New Chemical Entities (NCE) Product
 Table 95. Intertek Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 96. Intertek Recent Development
 Table 97. Neuland Laboratories Company Details
 Table 98. Neuland Laboratories Business Overview
 Table 99. Neuland Laboratories New Chemical Entities (NCE) Product
 Table 100. Neuland Laboratories Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 101. Neuland Laboratories Recent Development
 Table 102. Piramal Pharma Solutions Company Details
 Table 103. Piramal Pharma Solutions Business Overview
 Table 104. Piramal Pharma Solutions New Chemical Entities (NCE) Product
 Table 105. Piramal Pharma Solutions Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 106. Piramal Pharma Solutions Recent Development
 Table 107. Sai Life Sciences Company Details
 Table 108. Sai Life Sciences Business Overview
 Table 109. Sai Life Sciences New Chemical Entities (NCE) Product
 Table 110. Sai Life Sciences Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 111. Sai Life Sciences Recent Development
 Table 112. Chempro Pharma Company Details
 Table 113. Chempro Pharma Business Overview
 Table 114. Chempro Pharma New Chemical Entities (NCE) Product
 Table 115. Chempro Pharma Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 116. Chempro Pharma Recent Development
 Table 117. LG Chem Company Details
 Table 118. LG Chem Business Overview
 Table 119. LG Chem New Chemical Entities (NCE) Product
 Table 120. LG Chem Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 121. LG Chem Recent Development
 Table 122. Sofpromed Company Details
 Table 123. Sofpromed Business Overview
 Table 124. Sofpromed New Chemical Entities (NCE) Product
 Table 125. Sofpromed Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 126. Sofpromed Recent Development
 Table 127. Aurigene Pharmaceutical Services Ltd. Company Details
 Table 128. Aurigene Pharmaceutical Services Ltd. Business Overview
 Table 129. Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Product
 Table 130. Aurigene Pharmaceutical Services Ltd. Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 131. Aurigene Pharmaceutical Services Ltd. Recent Development
 Table 132. Aragen Life Sciences Ltd Company Details
 Table 133. Aragen Life Sciences Ltd Business Overview
 Table 134. Aragen Life Sciences Ltd New Chemical Entities (NCE) Product
 Table 135. Aragen Life Sciences Ltd Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 136. Aragen Life Sciences Ltd Recent Development
 Table 137. WuXi AppTec Company Details
 Table 138. WuXi AppTec Business Overview
 Table 139. WuXi AppTec New Chemical Entities (NCE) Product
 Table 140. WuXi AppTec Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 141. WuXi AppTec Recent Development
 Table 142. PharmaBlock Sciences Nanjing Inc Company Details
 Table 143. PharmaBlock Sciences Nanjing Inc Business Overview
 Table 144. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Product
 Table 145. PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) Business (2020-2025) & (US$ Million)
 Table 146. PharmaBlock Sciences Nanjing Inc Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. New Chemical Entities (NCE) Picture
 Figure 2. Global New Chemical Entities (NCE) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global New Chemical Entities (NCE) Market Share by Type: 2024 VS 2031
 Figure 4. NCE Discovery Features
 Figure 5. Drug Formulation Development Features
 Figure 6. Large-scale Manufacturing Features
 Figure 7. Global New Chemical Entities (NCE) Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global New Chemical Entities (NCE) Market Share by Application: 2024 VS 2031
 Figure 9. Tumors Case Studies
 Figure 10. Cardiovascular Diseases Case Studies
 Figure 11. Other Case Studies
 Figure 12. New Chemical Entities (NCE) Report Years Considered
 Figure 13. Global New Chemical Entities (NCE) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global New Chemical Entities (NCE) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global New Chemical Entities (NCE) Market Share by Region: 2024 VS 2031
 Figure 16. Global New Chemical Entities (NCE) Market Share by Players in 2024
 Figure 17. Global Top New Chemical Entities (NCE) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by New Chemical Entities (NCE) Revenue in 2024
 Figure 19. North America New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America New Chemical Entities (NCE) Market Share by Country (2020-2031)
 Figure 21. United States New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe New Chemical Entities (NCE) Market Share by Country (2020-2031)
 Figure 25. Germany New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific New Chemical Entities (NCE) Market Share by Region (2020-2031)
 Figure 33. China New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America New Chemical Entities (NCE) Market Share by Country (2020-2031)
 Figure 41. Mexico New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa New Chemical Entities (NCE) Market Share by Country (2020-2031)
 Figure 45. Turkey New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE New Chemical Entities (NCE) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. KATSURA CHEMICAL CO., LTD Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 49. NMS Group (Accelera Srl) Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 50. Adragos Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 51. Syngene Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 52. Regis Custom API Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 53. Bachem Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 54. Suven Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 55. Aspen API Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 56. MedPharm Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 57. Intertek Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 58. Neuland Laboratories Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 59. Piramal Pharma Solutions Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 60. Sai Life Sciences Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 61. Chempro Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 62. LG Chem Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 63. Sofpromed Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 64. Aurigene Pharmaceutical Services Ltd. Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 65. Aragen Life Sciences Ltd Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 66. WuXi AppTec Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 67. PharmaBlock Sciences Nanjing Inc Revenue Growth Rate in New Chemical Entities (NCE) Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Chemical Drug CDMO Market Research Report 2024
Global Metal Ion Chelator Market Research Report 2025
Global Drug Discovery CRO Market Research Report 2025
Global Paper Release Agent Market Research Report 2025
Global Polymer Antibacterial Agent Market Research Report 2025
Global Textile Antistatic Agent Market Research Report 2025
Global Drug Discovery Software Market Insights Forecast to 2030
Global Antibacterial Additives Market Research Report 2025
Global Alkaline Curing Agent for Epoxy Resin Market Research Report 2025
Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Purity Alkanolamide Market Research Report 2025
Drug Discovery and Preclinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global New Chemical Entities NCE CDMO Market Research Report 2025
Global Molecular Imaging Agents Market Research Report 2024
Global Chemical Drug CXO Services Market Research Report 2024
Global New Electronic Chemical Materials Market Research Report 2024
Investigational New Drug Contract Development and Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computational Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Epoxy Resin Acid Curing Agent Market Research Report 2025
Global Large Molecule Drug Substance CDMO Market Research Report 2024

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions